Goose,

Putting medical degrees aside, typing opinions and calling them "truth bombs" should get some peer-reviewed pushback every time, even on an anonymous board.

imo, Ohm's List is an outstanding work-in-progress, the result of much time and effort/due diligence. It's a list of potential indications for the use of leronlimab. More short or long trials are needed for further evaluation. LL may help for every disease on the list, but maybe not.

In the meantime, it'd be great to get approval for one indication, and to start dreaming about helping people with off-label use of our molecule.

Best.